Cargando…
Thiostrepton-Nanomedicine, a TLR9 Inhibitor, Attenuates Sepsis-Induced Inflammation in Mice
Sepsis is a life-threatening clinical condition caused by infection and transposition of pathogens and pathogen-associated molecular patterns (PAMPs) into the host bloodstream. During sepsis, activation of toll-like receptors (TLRs) on immune cells triggers the release of pro-inflammatory cytokines...
Autores principales: | Esparza, K., Oliveira, S. D., Castellon, M., Minshall, R. D., Onyuksel, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471450/ https://www.ncbi.nlm.nih.gov/pubmed/37662481 http://dx.doi.org/10.1155/2023/4035516 |
Ejemplares similares
-
Proteomic analysis reveals a role for PAX8 in peritoneal colonization
of high grade serous ovarian cancer that can be targeted with micelle
encapsulated thiostrepton
por: Hardy, Laura R., et al.
Publicado: (2019) -
Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis
por: Khaja, Fatima, et al.
Publicado: (2016) -
Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy
por: Wang, Yan, et al.
Publicado: (2020) -
Administration of a TLR9 Inhibitor Attenuates the Development and Progression of Heart Failure in Mice
por: Ueda, Hiromichi, et al.
Publicado: (2019) -
Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells
por: Pandit, Bulbul, et al.
Publicado: (2011)